EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Streamlined Fragment-Based Discovery Platform for Targeting Structured RNAs

Yilin Jia, Amirhossein Taghavi, Patrick R A Zanon iD, Matthew D Disney iD

ACS Chemical Biology · 2025

DOI: 10.1021/acschembio.5c00372 ↗

At a glance

Journal article in ACS Chemical Biology, 2025. Written by Yilin Jia and 3 co-authors. Institution: Department of Chemistry, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, 130 Scripps Way, Jupiter, Florida 33458, U…. Major MEDLINE topics: RNA, Drug Discovery, Small Molecule Libraries. Cited 2 times so far (Crossref); 72 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NINDS NIH HHS, NIH HHS, National Institute of Neurological Disorders and Stroke.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Fragment-based drug discovery typically relies on specialized spectrometric methods to identify low-affinity compounds that bind to biomolecules. Here, we report a proof-of-concept study on the development of a streamlined fragment-based screening platform for small molecules targeting RNA. This method employs low molecular weight fragments appended with a diazirine reactive moiety and an alkyne tag. Upon photolysis and click chemistry with an azide-containing fluorophore, these compounds can be visualized for binding to the r(CUG) repeat expansion [r(CUG)exp] implicated in myotonic dystrophy type 1 (DM1). Fragments were found to bind the 1 × 1 nucleotide U/U internal loops formed when r(CUG)exp folds, guiding the design of homodimeric compounds capable of interacting with adjacent internal loops in a single molecule. One dimeric compound exhibited enhanced affinity and was converted into a proximity-induced covalent binder for prolonged target occupancy. This work establishes a versatile platform for targeting structured RNAs with potential applications across a variety of disease-relevant RNA targets.

Subjects

MeSH terms (MEDLINE)

RNADrug DiscoverySmall Molecule LibrariesClick ChemistryHumansDiazomethaneAlkynesNucleic Acid Conformation

Substances

RNASmall Molecule LibrariesDiazomethaneAlkynes

Authors and institutions

  • Department of Chemistry, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, 130 Scripps Way, Jupiter, Florida 33458, United States.
  • Department of Chemistry, The Scripps Research Institute, 130 Scripps Way, Jupiter, Florida 33458, United States.

ORCID profiles: Patrick R A Zanon, Matthew D Disney

Funding

  • NINDS NIH HHS
  • NIH HHS
  • National Institute of Neurological Disorders and Stroke
  • Deutsche Forschungsgemeinschaft
  • Muscular Dystrophy Association

Cite

APA

Jia, Y., Taghavi, A., Zanon, P. R. A., & Disney, M. D. (2025). Streamlined Fragment-Based Discovery Platform for Targeting Structured RNAs. ACS Chemical Biology. https://doi.org/10.1021/acschembio.5c00372

Vancouver

Jia Y, Taghavi A, Zanon PRA, Disney MD. Streamlined Fragment-Based Discovery Platform for Targeting Structured RNAs. ACS Chemical Biology. 2025. doi:10.1021/acschembio.5c00372

BibTeX
@article{Jia2025,
  author = {Jia, Yilin and Taghavi, Amirhossein and Zanon, Patrick R A and Disney, Matthew D},
  title = {Streamlined Fragment-Based Discovery Platform for Targeting Structured RNAs},
  journal = {ACS Chemical Biology},
  year = {2025},
  doi = {10.1021/acschembio.5c00372}
}
Start for free →